Search research articles
Contact Us
Filters
Showing results (81-90 of 115) with videos related to
Page
of 12
Sort By:
Journal of the American Dietetic Association
|
September 1, 1994
The Eating Pattern Assessment Tool: a simple instrument for assessing dietary fat and cholesterol intake
J R Peters, E S Quiter, M L Brekke, et al.
Annals of Internal Medicine
|
October 2, 2001
Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen/progestin Replacement Study
J A Simon, D B Hunninghake, S K Agarwal, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 1, 1993
Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and human
R A Halpin, E H Ulm, A E Till, et al.
The American Journal of Cardiology
|
November 14, 1997
Rationale, design, and baseline characteristics of the Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT)
R P Byington, M E Miller, D Herrington, et al.
The American Journal of Cardiology
|
August 15, 1992
Factors influencing the development of hypercholesterolemia after cardiac transplantation
S H Kubo, J R Peters, K R Knutson, et al.
Vascular Medicine (London, England)
|
September 4, 2001
The Minnesota Regional Peripheral Arterial Disease Screening Program: toward a definition of community standards of care
A T Hirsch, S L Halverson, D Treat-Jacobson, et al.
The American Journal of Clinical Nutrition
|
May 1, 1994
Hypocholesterolemic effects of a dietary fiber supplement
D B Hunninghake, V T Miller, J C LaRosa, et al.
Journal of Thrombosis and Thrombolysis
|
June 22, 1999
Hemostatic effects of 1 mg daily warfarin on post CABG patients. Post CABG Studies Investigators
J M Walenga, D Hoppensteadt, R Pifarré, et al.
Atherosclerosis
|
December 1, 1990
Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. II. Once-daily versus twice-daily dosing
D B Hunninghake, M J Mellies, A C Goldberg, et al.
JAMA
|
September 9, 2000
Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: A randomized trial. Arterial Disease Multiple Intervention Trial
M B Elam, D B Hunninghake, K B Davis, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 115) with videos related to
Sort By:
Page
of 12
Journal of the American Dietetic Association
|
September 1, 1994
The Eating Pattern Assessment Tool: a simple instrument for assessing dietary fat and cholesterol intake
J R Peters, E S Quiter, M L Brekke, et al.
Annals of Internal Medicine
|
October 2, 2001
Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen/progestin Replacement Study
J A Simon, D B Hunninghake, S K Agarwal, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 1, 1993
Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and human
R A Halpin, E H Ulm, A E Till, et al.
The American Journal of Cardiology
|
November 14, 1997
Rationale, design, and baseline characteristics of the Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT)
R P Byington, M E Miller, D Herrington, et al.
The American Journal of Cardiology
|
August 15, 1992
Factors influencing the development of hypercholesterolemia after cardiac transplantation
S H Kubo, J R Peters, K R Knutson, et al.
Vascular Medicine (London, England)
|
September 4, 2001
The Minnesota Regional Peripheral Arterial Disease Screening Program: toward a definition of community standards of care
A T Hirsch, S L Halverson, D Treat-Jacobson, et al.
The American Journal of Clinical Nutrition
|
May 1, 1994
Hypocholesterolemic effects of a dietary fiber supplement
D B Hunninghake, V T Miller, J C LaRosa, et al.
Journal of Thrombosis and Thrombolysis
|
June 22, 1999
Hemostatic effects of 1 mg daily warfarin on post CABG patients. Post CABG Studies Investigators
J M Walenga, D Hoppensteadt, R Pifarré, et al.
Atherosclerosis
|
December 1, 1990
Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. II. Once-daily versus twice-daily dosing
D B Hunninghake, M J Mellies, A C Goldberg, et al.
JAMA
|
September 9, 2000
Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: A randomized trial. Arterial Disease Multiple Intervention Trial
M B Elam, D B Hunninghake, K B Davis, et al.
Page
of 12